Alert detail
LCD L36425: MolDX: Breast Cancer Assay: Prosigna® — CGS
What changed
New coverage for Prosigna® assay may boost breast cancer testing profits.
Who’s affected: Oncology billing teams · Effective: March 19, 2026
Primary source: View the official CMS/MAC document ↗
Get the action steps and full analysis
This change affects 4 billing codes.
The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.